Novartis Pharma Services Romania S.R.L.
Novartis Pharma Services Romania S.R.L., a subsidiary of the global healthcare leader Novartis, is headquartered in Romania and operates extensively across Eastern Europe. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies that address unmet medical needs. Specialising in areas such as oncology, cardiology, and immunology, Novartis Pharma Services Romania is renowned for its commitment to research and development, delivering unique products that enhance patient outcomes. The company has achieved significant milestones, including the launch of groundbreaking treatments that have transformed patient care. With a strong market position, Novartis Pharma Services Romania continues to contribute to the healthcare landscape, driven by a mission to improve and extend people's lives through science and innovation.
DitchCarbon Score
How does Novartis Pharma Services Romania S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharma Services Romania S.R.L.'s score of 62 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharma Services Romania S.R.L.'s reported carbon emissions
Novartis Pharma Services Romania S.R.L. currently does not have available carbon emissions data, as no specific figures have been provided. Consequently, there are no reported emissions for the most recent year or any previous years. Additionally, the company has not outlined any formal reduction targets or commitments related to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data, it is important to note that many pharmaceutical companies are increasingly focusing on sustainability and reducing their carbon footprints. This often includes initiatives aimed at minimising Scope 1, 2, and 3 emissions, which encompass direct emissions from owned or controlled sources, indirect emissions from the generation of purchased energy, and other indirect emissions in the value chain, respectively. As the industry evolves, Novartis Pharma Services Romania S.R.L. may adopt similar strategies to enhance their climate commitments and contribute to global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novartis Pharma Services Romania S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
